# Symptoms and Endoscopic Results in Consideration of Pretreatment

> **NCT00612404** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 16255 (actual)

## Conditions studied

- Gastrointestinal Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00612404
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-09
- **Primary completion:** 2005-12
- **Final completion:** —
- **Target enrollment:** 16255 (ACTUAL)
- **Last updated:** 2008-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00612404

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00612404, "Symptoms and Endoscopic Results in Consideration of Pretreatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00612404. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*